Skip to main content
Cigna Group logo

Cigna Group — Investor Relations & Filings

Ticker · CI ISIN · US1255231003 LEI · 549300VIWYMSIGT1U456 US Financial and insurance activities
Open in API
Filings indexed 989 across all filing types
Latest filing 2018-07-16 Proxy Solicitation & In…
Country US United States of America
Listing US CI

About Cigna Group

https://www.thecignagroup.com/

The Cigna Group is a global health company that operates through two primary divisions: Cigna Healthcare and Evernorth Health Services. Cigna Healthcare provides a range of health benefit plans and services, including medical and dental insurance, to a diverse client base that encompasses U.S. employers, U.S. government programs, and international markets. Evernorth Health Services offers a portfolio of pharmacy, care delivery, and benefits solutions. The company's integrated approach aims to improve health outcomes and vitality for its customers by increasing the affordability, predictability, and simplicity of healthcare.

Recent filings

Filing Released Lang Actions
424B3
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed merger proposal and proxy solicitation related to the merger agreement between Cigna Corporation and Express Scripts Holding Company. It includes notices of special meetings of stockholders to vote on the merger agreement and related proposals. The text references a joint proxy statement/prospectus and urges stockholders to vote, indicating it is a solicitation for shareholder votes on merger-related matters. This fits the definition of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not a full merger agreement filing (MA) or a simple announcement but a comprehensive proxy statement/prospectus related to the merger vote. Therefore, the correct classification is PSI with high confidence.
2018-07-16 English
S-4/A
M&A Activity Classification · 100% confidence The document is an Amendment No. 4 to Form S-4 Registration Statement filed with the SEC, which is a registration statement used for securities issued in connection with mergers and acquisitions. The text includes detailed information about a merger proposal between Cigna Corporation and Express Scripts Holding Company, including the merger agreement, stockholder meetings to vote on the merger, and proxy solicitation details. It is not a financial report, earnings release, or annual report, but rather a regulatory filing related to a merger transaction. The presence of the joint proxy statement/prospectus and the merger agreement details indicate this is a filing related to M&A activity. Therefore, the appropriate classification is Merger & Acquisition (MA). The document length and content confirm it is not a mere announcement but a substantive filing related to the merger.
2018-07-14 English
Regulatory Filings 2018
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-4. It references the Registration Statement and requests the SEC to make it effective by a certain date and time. The content is a formal request related to a filing process rather than the filing itself or a report containing financial data. The document length is short (2036 characters), and it does not contain financial statements or detailed report content. Therefore, it is an announcement or correspondence related to a regulatory filing, not the filing itself. According to the rules, such correspondence should be classified as Regulatory Filings (RNS).
2018-07-12 English
Regulatory Filings 2018
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel responding to SEC staff comments regarding an Amendment No. 2 to a Registration Statement on Form S-4 related to Cigna's proposed acquisition of Express Scripts. It discusses revisions to the Registration Statement and provides clarifications on merger-related disclosures. The document is correspondence about a merger transaction and the filing of amendments to a registration statement, not the registration statement itself or a full merger filing. It is not a full merger proxy or tender offer filing (MA), nor is it a financial report or earnings release. It is a regulatory correspondence related to a merger registration statement. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2018-07-12 English
S-4/A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an Amendment No. 3 to Form S-4 Registration Statement filed with the SEC, dated July 11, 2018. It relates to a merger transaction between Cigna Corporation and Express Scripts Holding Company. The text includes detailed information about the merger proposal, voting procedures for stockholders, and proxy solicitation for the special meetings to approve the merger agreement. It is a joint proxy statement/prospectus, which is a solicitation document sent to shareholders to provide information and request votes for the merger-related proposals. The document is not a full annual report, earnings release, or audit report, nor is it a simple announcement or certification. It is specifically a proxy solicitation document related to a merger transaction. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is the actual solicitation document, not just an announcement or notice.
2018-07-12 English
Regulatory Filings 2018
Regulatory Filings
2018-07-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.